Investors

Regulated information, press releases, financial reports...

Short cuts for investors

Key publications

Main Webcasts

  • ICML 2019: IPH4102 TELLOMAK KOL call > see
  • ASH 2018: Updated results on IPH4102 > see
  • ESMO 2018: Phase II trial of monalizumab and cetuximab > see
  • Expansion of oncology development collaboration with AstraZeneca (October 23th, 2018)  > see

 

Regulated information & publications